(Q43805976)

27 November 2017

title

Gln27Glu beta2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver (English)

1 reference

27 November 2017

1 reference

Iwamoto N

1

1 reference

27 November 2017

Ogawa Y

2

1 reference

27 November 2017

Kajihara S

3

1 reference

27 November 2017

Hisatomi A

4

1 reference

27 November 2017

Yasutake T

5

1 reference

27 November 2017

Yoshimura T

6

1 reference

27 November 2017

Mizuta T

7

1 reference

27 November 2017

Hara T

8

1 reference

27 November 2017

Ozaki I

9

1 reference

27 November 2017

Yamamoto K

10

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

314

1 reference

27 November 2017

issue

1-2

1 reference

27 November 2017

page(s)

85-91

1 reference

Body composition and hepatic steatosis as precursors for fibrotic liver disease

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

The biochemistry of alcohol-induced fatty liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Nonalcoholic steatohepatitis: An expanded clinical entity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Demonstration of an in vivo functional beta 3-adrenoceptor in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Lipolytic catecholamine resistance due to decreased beta 2-adrenoceptor expression in fat cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Time of Onset of Non-Insulin-Dependent Diabetes Mellitus and Genetic Variation in the β3-Adrenergic–Receptor Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Association of a polymorphism in the beta 3-adrenergic-receptor gene with features of the insulin resistance syndrome in Finns.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Association of the Trp64Arg mutation of the beta3-adrenergic receptor with fatty liver and mild glucose intolerance in Japanese subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Association of polymorphisms in the beta2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Prospective Study of Serum -Glutamyltransferase and Risk of NIDDM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Gln27Glu and Arg16Gly polymorphisms of the beta2-adrenergic receptor gene are not associated with obesity in Japanese men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Gln27Glu variant of the beta2-adrenergic receptor gene is not associated with obesity and diabetes in Japanese-Americans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

A mutation of the b3-adrenergic receptor is associated with visceral obesity but decreased serum triglyceride

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Polymorphisms of the 5' leader cistron of the human beta2-adrenergic receptor regulate receptor expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

Mobilisation of triacylglycerol stores

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2801%2900633-7

10.1016/S0009-8981(01)00633-7

7 January 2021

Identifiers

DOI

1 reference

27 November 2017

1 reference